fbpx
April 6, 2020

FDA Updates Pregnancy Information on Interferon-β Drug Labels FDA Updates Pregnancy Information on Interferon-β Drug Labels

The US Food and Drug Administration (FDA) has updated the prescribing information for peginterferon β-1a (Plegridy, Biogen) and interferon β-1a (Avonex, Biogen) regarding use during pregnancy […]
April 6, 2020

First Advance in MDS for Decade: Luspatercept for Anemia First Advance in MDS for Decade: Luspatercept for Anemia

The US Food and Drug Administration (FDA) has approved luspatercept (Reblozyl, Bristol-Myers Squibb/Acceleron) for the treatment of anemia in patients with myelodysplastic syndromes (MDS). The green light represents […]
April 4, 2020

FDA Approves First Rapid Antibody Test for COVID-19 FDA Approves First Rapid Antibody Test for COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use […]
April 3, 2020

EMA Restricts Fosfomycin Use Following Evidence Review EMA Restricts Fosfomycin Use Following Evidence Review

The European Medicines Agency (EMA) has recommended a number of changes regarding the use of fosfomycin-based antibiotics, including recommending the suspension of use of pediatric and […]
April 2, 2020

FDA Calls for Market Removal of Ranitidine FDA Calls for Market Removal of Ranitidine

A problem with probable human carcinogen N-nitrosodimethylamine (NDMA) contamination in ranitidine, commonly known by the brand name Zantac, has led the Food and Drug Administration to call for […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0